BORA PHARMACEUTICALS LTD (6472) — Cash Flow Reinvestment Rate
BORA PHARMACEUTICALS LTD (6472) has a Cash Flow Reinvestment Rate of 0.45x as of March 2026, reinvesting NT$258.50 Million (capex NT$211.08 Million plus investments NT$-47.42 Million) from operating cash flow of NT$568.46 Million. See 6472 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
BORA PHARMACEUTICALS LTD Cash Flow Reinvestment Rate (2019–2025)
Historical reinvestment intensity for BORA PHARMACEUTICALS LTD across 7 annual periods. For the full cash flow conversion analysis, see BORA PHARMACEUTICALS LTD cash conversion from operations.
Annual Cash Flow Reinvestment Rate for BORA PHARMACEUTICALS LTD (2019–2025)
Year-by-year capital reinvestment analysis for BORA PHARMACEUTICALS LTD. See how financially flexible is BORA PHARMACEUTICALS LTD to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (TWD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.22x | NT$953.00 Million | NT$4.24 Billion | NT$928.67 Million | ▼ -80.2% |
| 2024 | 1.13x | NT$1.11 Billion | NT$980.81 Million | NT$687.05 Million | ▲ +254.9% |
| 2023 | 0.32x | NT$1.47 Billion | NT$4.61 Billion | NT$1.43 Billion | ▲ +22.3% |
| 2022 | 0.26x | NT$524.20 Million | NT$2.01 Billion | NT$200.22 Million | ▼ -11.3% |
| 2021 | 0.29x | NT$363.58 Million | NT$1.24 Billion | NT$363.58 Million | ▼ -65.6% |
| 2020 | 0.86x | NT$152.09 Million | NT$177.79 Million | NT$152.09 Million | ▼ -71.6% |
| 2019 | 3.01x | NT$697.33 Million | NT$231.77 Million | NT$697.33 Million | — |